Search

Merck, Heritage Valley Health System, caught in global cyberattack

MERCK, HERITAGE VALLEY HEALTH SYSTEM, CAUGHT IN GLOBAL CYBERATTACK

On Tuesday, pharma giant Merck & Co confirmed its computer network had been compromised as part of a vicious new cybersecurity attack,...

 
 
 

MERCK KGAA, F-STAR IN BISPECIFIC BIOBUCKS BONANZA DEAL

The two countries' governments may not be getting along, but it's a marriage of science for Germany's Merck and U.K.-based F-Star for...

 
 
 
 
 
 
Sema4, Eric Schadt's Genomics Startup, Spins Out of Sinai to Raise Cash

SEMA4, ERIC SCHADT'S GENOMICS STARTUP, SPINS OUT OF SINAI TO RAISE CASH

Eric Schadt has been incubating a genomic data project within the Icahn School of Medicine at Mount Sinai for more than five years....

In Maine, Making Cancer DNA Tests Free-And Asking Tough Questions

IN MAINE, MAKING CANCER DNA TESTS FREE-AND ASKING TOUGH QUESTIONS

Has the era of genetic oncology arrived? Last week, the biomedical world took a notable step in that direction when the FDA said Merck's...

 
 
 

MERCK KGAA, DARMSTADT, GERMANY LICENSES SELEXIS SA SURETECHNOLOGY PLATFORM FOR IMMUNO-ONCOLOGY ANTIBODY PROGRAM

Life Sciences Jobs ...

What if the disease you're targeting isn't economically viable?

WHAT IF THE DISEASE YOU'RE TARGETING ISN'T ECONOMICALLY VIABLE?

San Diego-based Drugs & Diagnostics for Tropical Diseases has developed a cheap and practical test for mapping Loa loa infections in...

 
 
 
FDA approves drug to target a tumor's genetic traits

FDA APPROVES DRUG TO TARGET A TUMOR'S GENETIC TRAITS

Keytruda, made by Merck & Co, is a form of immunotherapy which targets solid tumors with certain biomarkers, rather than trying to...

 
 
 
Technical Services Manager - Swine

TECHNICAL SERVICES MANAGER - SWINE

Merck & Co., Inc. Kenilworth, N.J., U.S.A. known as Merck in the United States and Canada, is a global health care leader with a diversified...

Eli Lilly Migraine Drug Hits Study Goals, Paves Way for FDA Filing

ELI LILLY MIGRAINE DRUG HITS STUDY GOALS, PAVES WAY FOR FDA FILING

An Eli Lilly drug developed to stop migraine headaches before they can start hits its main goals in a late-stage clinical trial, the...

 
 
 
Merck tops Street 1Q forecasts

MERCK TOPS STREET 1Q FORECASTS

KENILWORTH, N.J. - Merck & Co. is reporting first-quarter earnings of $1.55 billion.

 
 
 

EX-MERCK R&D EXEC ROBERT PLENGE JUMPS SHIP TO CELGENE

Ex-Merck R&D exec Robert Plenge jumps ship to Celgene badams Mon, 05/01/2017 - 04:36

Phoenix Shops Its Cancer Drug as Potential Alzheimer's Treatment

PHOENIX SHOPS ITS CANCER DRUG AS POTENTIAL ALZHEIMER'S TREATMENT

San Antonio - George Perry, a scientist at the University of Texas at San Antonio, has long proposed that drug developers and researchers...

 
 
 
AI Startup Atomwise Has A Deal For Researchers Hunting For New Drugs

AI STARTUP ATOMWISE HAS A DEAL FOR RESEARCHERS HUNTING FOR NEW DRUGS

Artificial intelligence company Atomwise is offering a shortcut for as many as 100 university scientists who are searching for new...